REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
BAP1 (D7W7O) Rabbit mAb | Cell Signaling Technology | Cat# 13271; RRID:AB_2798168 |
RAP1A (C-10) Mouse mAb | Santa Cruz Biotechnology | Cat# sc-373968; RRID:AB_10917062 |
Tri-Methyl-Histone H3 (Lys27) (C36B11) Rabbit mAb | Cell Signaling Technology | Cat# 9733, RRID:AB_2616029 |
a-Tubulin Mouse mAb | Sigma-Aldrich | Cat# T9026, RRID:AB_477593 |
Goat anti-Rabbit IgG (H + L) Cross-Adsorbed Secondary Antibody, HRP | Thermo Fisher Scientific | Cat# G-21234, RRID:AB_2536530 |
Goat anti-Mouse IgG (H + L) Secondary Antibody, HRP | Thermo Fisher Scientific | Cat# 62-6520, RRID:AB_2533947 |
Bacterial and virus strains | ||
Mouse Kinome CRISPR Knockout Library (Brie) | Doench et al.21 | Addgene #75316 |
FH1-tUTG | Aubrey et al.48 | Addgene #70183 |
pLKO5.sgRNA.EFS.GFP | Heckl et al.49 | Addgene #57822 |
Chemicals, peptides, and recombinant proteins | ||
Zoledronic Acid | Medkoo Biosciences | 100950 CAS: 165800-06-6 |
GSK126 | Selleck Chemicals | S7061 CAS: 1346574-57-9 |
Tazemetostat | Medkoo Biosciences | 406265 CAS: 1403254-99-8 |
Lovastatin (MK-803) | Selleck Chemicals | S2061 CAS: 75330-75-5 |
Terbinafine HCl (KWD 201) | Selleck Chemicals | S2557 CAS: 78628-80-5 |
Critical commercial assays | ||
ReliaPrep™ RNA Miniprep Systems | Promega | Cat# Z6012 |
Tetro cDNA synthesis kit | Meridian Bioscience | Cat# BIO-65043 |
Deposited data | ||
RNA sequencing data | This paper | GSE222376 |
CRISPR/CAS9-screen MAGeCK results | This paper | Data available upon request |
Patient survival and expression data (upon consent) | Genentech | EGAS00001001563 |
ChIP-seq data | This paper | GSE145022 |
Experimental models: Cell lines | ||
Human: NCI-H226 | Wellcome Trust Sanger Institute | RRID:CVCL_1544 |
Human: NCI-H226 + BAP1 WT | Wellcome Trust Sanger Institute | N/A |
Human: NCI-H2452 | Wellcome Trust Sanger Institute | RRID:CVCL_1553 |
Human: NCI-H2731 | Wellcome Trust Sanger Institute | RRID:CVCL_U995 |
Human: NCI-H28 | Wellcome Trust Sanger Institute | RRID:CVCL_1555 |
Human: NCI-H2804 | Wellcome Trust Sanger Institute | RRID:CVCL_U998 |
Human: NCI-H2810 | Wellcome Trust Sanger Institute | RRID:CVCL_U999 |
Human: NCI-H2818 | Wellcome Trust Sanger Institute | RRID:CVCL_V000 |
Human: MSTO-211H | ATCC | RRID:CVCL_1430 |
Human: MPP-89 | Wellcome Trust Sanger Institute | RRID:CVCL_1427 |
Human: MP38 | Wellcome Trust Sanger Institute | RRID:CVCL_4D11 |
Human: MP41 | Wellcome Trust Sanger Institute | RRID:CVCL_4D12 |
Human: MP46 | Wellcome Trust Sanger Institute | RRID:CVCL_4D13 |
Human: Mel270 | Wellcome Trust Sanger Institute | RRID:CVCL_C302 |
Human: MM28 | Wellcome Trust Sanger Institute | RRID:CVCL_4D15 |
Human: MM66 | Wellcome Trust Sanger Institute | RRID:CVCL_4D17 |
Human: OMM.1 | Wellcome Trust Sanger Institute | RRID:CVCL_6939 |
Human: 92.1 | Wellcome Trust Sanger Institute | RRID:CVCL_8607 |
Mouse: NC | Badhai et al.15 | N/A |
Mouse: BNC | Badhai et al.15 | N/A |
Mouse: BNCP | Badhai et al.15 | N/A |
Experimental models: Organisms/strains | ||
Mouse: NOD-Scid IL2Rγnull | Jackson Laboratory | RRID:IMSR_JAX:005557 |
Mouse: Autochthonous Bap1-deficient mesothelioma model | Badhai et al.15 | N/A |
Oligonucleotides | ||
sgRNA targeting sequence: Mvk: CACCGCAAGGTCCCGCGGAGTACCA |
This paper | N/A |
sgRNA targeting sequence: Pmvk: CACCGCTCTCTGGTCCACTCAAGG |
This paper | N/A |
Inducible shRNA targeting sequence: BAP1: GAGUUCAUCUGCACCUUUA |
This paper | N/A |
(ChIP-)qPCR primers see Table S1 | This paper | N/A |
Recombinant DNA | ||
Software and algorithms | ||
GraphPad Prism v.9 | GraphpadSoftware | https://www.graphpad.com:443/ |
FlowJo v.10.6.0 | FlowJo, LLC | https://www.flowjo.com/ |
R (v4.1.1) | R | https://cran.r-project.org/ |
RStudio (v1.4.1106) | RStudio, PBC | https://www.rstudio.com/ |
DESeq2 (version1.30.1) | Love et al.50 | https://bioconductor.org/packages/release/bioc/html/DESeq2.html |
MAGeCK algorithm (v0.5.9.4) | Li et al.51 | https://sourceforge.net/p/mageck/wiki/ |
GSEA (v4.1.0) | UC San Diego | https://www.gsea-msigdb.org/gsea/index.jsp |